B L Hazleman

11.4k total citations
144 papers, 7.9k citations indexed

About

B L Hazleman is a scholar working on Surgery, Rheumatology and Orthopedics and Sports Medicine. According to data from OpenAlex, B L Hazleman has authored 144 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 50 papers in Rheumatology and 24 papers in Orthopedics and Sports Medicine. Recurrent topics in B L Hazleman's work include Shoulder Injury and Treatment (43 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Tendon Structure and Treatment (20 papers). B L Hazleman is often cited by papers focused on Shoulder Injury and Treatment (43 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Tendon Structure and Treatment (20 papers). B L Hazleman collaborates with scholars based in United Kingdom, United States and Australia. B L Hazleman's co-authors include Graham P. Riley, Tim E. Cawston, M D Chard, R L Harrall, Allan Binder, Cathy Speed, Andrew J.K. Östör, D Y Bulgen, Sarah Roberts and Valerie Curry and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Biochemical Journal.

In The Last Decade

B L Hazleman

140 papers receiving 7.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B L Hazleman United Kingdom 49 4.3k 2.5k 1.8k 1.4k 767 144 7.9k
Kenji Takagishi Japan 45 4.5k 1.0× 1.4k 0.5× 1.6k 0.9× 1.8k 1.3× 584 0.8× 323 8.0k
Ching‐Jen Wang Taiwan 54 5.3k 1.2× 4.4k 1.8× 1.2k 0.7× 693 0.5× 445 0.6× 211 9.1k
Κonstantinos Ν. Malizos Greece 50 4.9k 1.1× 1.8k 0.7× 1.3k 0.7× 2.3k 1.7× 463 0.6× 215 8.2k
Simon Donell United Kingdom 50 4.9k 1.1× 2.8k 1.1× 1.2k 0.7× 1.6k 1.2× 370 0.5× 212 8.5k
Katsuro Tomita Japan 53 6.4k 1.5× 669 0.3× 846 0.5× 1.5k 1.1× 492 0.6× 285 10.3k
Robert F. Diegelmann United States 51 2.3k 0.5× 782 0.3× 735 0.4× 605 0.4× 215 0.3× 152 9.7k
Hisashi Iwata Japan 48 2.6k 0.6× 673 0.3× 468 0.3× 1.1k 0.8× 364 0.5× 281 6.4k
Thomas Pufe Germany 49 1.8k 0.4× 1.4k 0.6× 451 0.3× 1.2k 0.9× 445 0.6× 195 7.1k
José Vicente Bagán Sebastián Spain 50 1.3k 0.3× 886 0.4× 696 0.4× 866 0.6× 321 0.4× 287 9.2k
G. Nuki United Kingdom 37 2.8k 0.6× 1.1k 0.4× 576 0.3× 5.2k 3.8× 2.0k 2.6× 153 9.1k

Countries citing papers authored by B L Hazleman

Since Specialization
Citations

This map shows the geographic impact of B L Hazleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B L Hazleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B L Hazleman more than expected).

Fields of papers citing papers by B L Hazleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B L Hazleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B L Hazleman. The network helps show where B L Hazleman may publish in the future.

Co-authorship network of co-authors of B L Hazleman

This figure shows the co-authorship network connecting the top 25 collaborators of B L Hazleman. A scholar is included among the top collaborators of B L Hazleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B L Hazleman. B L Hazleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kudrin, Alex, Edwin R. Chilvers, B L Hazleman, et al.. (2007). Sarcoid-like granulomatous disease following etanercept treatment for RA.. PubMed. 34(3). 648–9. 47 indexed citations
2.
Östör, Andrew J.K., C. Richards, A Toby Prevost, Cathy Speed, & B L Hazleman. (2005). Diagnosis and relation to general health of shoulder disorders presenting to primary care. Lara D. Veeken. 44(6). 800–805. 292 indexed citations
3.
Corps, Anthony N., A. H. N. Robinson, Tomas Movin, et al.. (2005). Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Lara D. Veeken. 45(3). 291–294. 120 indexed citations
4.
Östör, Andrew J.K., et al.. (2004). Interrater reproducibility of clinical tests for rotator cuff lesions. Annals of the Rheumatic Diseases. 63(10). 1288–1292. 41 indexed citations
5.
Riley, Graham P., Valerie Curry, Jeroen DeGroot, et al.. (2002). Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biology. 21(2). 185–195. 296 indexed citations
6.
Östör, Andrew J.K. & B L Hazleman. (2002). Managing the patient with polymyalgia.. PubMed. 246(1640). 756, 759–63.
7.
Riley, Graham P., R L Harrall, C. R. Constant, Tim E. Cawston, & B L Hazleman. (1996). Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration.. Annals of the Rheumatic Diseases. 55(2). 109–115. 63 indexed citations
8.
Vecchio, Phillip, B L Hazleman, & Ryan King. (1993). A DOUBLE-BLIND TRIAL COMPARING SUBACROMIAL METHYLPREDNISOLONE AND LIGNOCALNE IN ACUTE ROTATOR CUFF TENDINITIS. Lara D. Veeken. 32(8). 743–745. 62 indexed citations
9.
Isaacs, John D., Richard A. Watts, B L Hazleman, G Hale, & Herman Waldmann. (1992). HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS. Oxford University Research Archive (ORA) (University of Oxford). 35. 7 indexed citations
10.
Adebajo, Ade & B L Hazleman. (1992). SOFT TISSUE SHOULDER LESIONS IN THE AFRICAN. Lara D. Veeken. 31(4). 275–276. 10 indexed citations
11.
Hazleman, B L. (1991). CLINICAL CONUNDRUM. Lara D. Veeken. 30(1). 34–34. 3 indexed citations
12.
Cawston, Tim E., et al.. (1990). Modulation of plasminogen activator production by interleukin 1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1051(1). 84–93. 7 indexed citations
13.
Cawston, Tim, P. McLaughlan, Robert J. Coughlan, V Kyle, & B L Hazleman. (1990). Synovial fluids from infected joints contain metalloproteinase — tissue inhibitor of metalloproteinase (TIMP) complexes. Biochimica et Biophysica Acta (BBA) - General Subjects. 1033(1). 96–102. 11 indexed citations
14.
Adebajo, Adewale & B L Hazleman. (1990). Shoulder pain and reflex sympathetic dystrophy. Current Opinion in Rheumatology. 2(2). 270–275. 2 indexed citations
15.
Silverman, Barbara, T. E. Cawston, D. P. Page Thomas, J. T. Dingle, & B L Hazleman. (1990). THE SULPHATED GLYCOSAMINOGLYCAN LEVELS IN SYNOVIAL FLUID ASPIRATES IN PATIENTS WITH ACUTE AND CHRONIC JOINT DISEASE. Lara D. Veeken. 29(5). 340–344. 6 indexed citations
16.
Smith, Andrew J. O., et al.. (1989). The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblastsin vitro. Inflammation Research. 28(3-4). 279–282. 14 indexed citations
17.
Dieppe, Paul, Tim Cawston, Elizabeth Mercer, et al.. (1988). Synovial fluid collagenase in patients with destructive arthritis of the shoulder joint. Arthritis & Rheumatism. 31(7). 882–890. 16 indexed citations
18.
Chard, M D, et al.. (1987). Isolation and growth characteristics of adult human tendon fibroblasts.. Annals of the Rheumatic Diseases. 46(5). 385–390. 21 indexed citations
19.
Kyle, V, Barbara Silverman, A J Silman, et al.. (1985). Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice.. BMJ. 291(6492). 385–387. 10 indexed citations
20.
Hazleman, B L. (1985). Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. The American Journal of Medicine. 78(1). 39–43. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Takagishi Breakdown of academic impact, for papers by Ching‐Jen Wang Breakdown of academic impact, for papers by Κonstantinos Ν. Malizos Breakdown of academic impact, for papers by Simon Donell Breakdown of academic impact, for papers by Katsuro Tomita Breakdown of academic impact, for papers by Robert F. Diegelmann Breakdown of academic impact, for papers by Hisashi Iwata Breakdown of academic impact, for papers by Thomas Pufe Breakdown of academic impact, for papers by José Vicente Bagán Sebastián Breakdown of academic impact, for papers by G. Nuki
Rankless by CCL
2026